Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints

Glaucoma clinical trials using visual field (VF) endpoints currently require large sample sizes because of the slowly-progressive nature of this disease. We sought to examine whether the combined use of VF testing and non-invasive optical coherence tomography (OCT) imaging of the neuroretinal tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhichao, Medeiros, Felipe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906445/
https://www.ncbi.nlm.nih.gov/pubmed/31827169
http://dx.doi.org/10.1038/s41598-019-55345-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906445/
https://www.ncbi.nlm.nih.gov/pubmed/31827169
http://dx.doi.org/10.1038/s41598-019-55345-x

Ejemplares similares